Results of Poisson regression with generalised estimating equations to investigate the relationship between stroke incidence and medication adherence
Variables | Stroke | ||
Adjusted RR | 95% CI | p Value | |
Medication adherence (medical possession rate, MPR) | |||
High adherence (MPR≥0.8) | 1.00 | – | |
Intermediate adherence (0.5≤MPR<0.8) | 1.13 | 1.06 to 1.21 | 0.0004 |
Poor adherence (MPR<0.5) | 1.27 | 1.17 to 1.38 | <0.0001 |
Age | |||
30–49 | 1.00 | – | |
50–59 | 1.73 | 1.46 to 2.04 | <0.0001 |
60–69 | 2.90 | 2.39 to 3.52 | <0.0001 |
70 | 4.76 | 3.83 to 5.93 | <0.0001 |
Sex | |||
Men | 1.00 | – | |
Women | 0.77 | 0.68 to 0.87 | <0.0001 |
Income | |||
Medical aid | 1.39 | 0.93 to 2.06 | 0.1049 |
Low (0%–20%) | 1.00 | – | |
Middle (20.1%–80%) | 0.94 | 0.87 to 1.03 | 0.1741 |
High (80.1%–100%) | 0.98 | 0.88 to 1.09 | 0.7204 |
Region | |||
Urban | 1.00 | – | |
Rural | 1.22 | 1.10 to 1.35 | 0.0002 |
Charlson Comorbidity Index | 1.05 | 1.01 to 1.09 | 0.0081 |
Metabolic syndrome | |||
Absence | 1.00 | – | |
Presence | 1.09 | 1.03 to 1.14 | 0.0016 |
Family history of stroke | |||
Absence | 1.00 | – | |
Presence | 1.13 | 1.03 to 1.24 | 0.0110 |
Number of antihypertensive medication | |||
One | 1.00 | – | |
More than 1 | 1.03 | 0.97 to 1.10 | 0.3651 |
Duration of hypertension (year) | |||
≤2 | 1.00 | ||
2–5 | 1.16 | 1.09 to 1.24 | <0.0001 |
5–10 | 1.44 | 1.30 to 1.60 | <0.0001 |
Year | |||
2009 | 1.00 | – | |
2010 | 2.58 | 2.39 to 2.77 | <0.0001 |
2011 | 1.99 | 1.86 to 2.12 | <0.0001 |
2012 | 1.66 | 1.58 to 1.73 | <0.0001 |
2013 | 1.25 | 1.17 to 1.33 | <0.0001 |
RR, relative risk.